383 related articles for article (PubMed ID: 16498518)
1. Metabolic syndrome: a marker of patients at high cardiovascular risk.
Lau DC; Yan H; Dhillon B
Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):85B-90B. PubMed ID: 16498518
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of the insulin resistance syndrome.
Meigs JB
Curr Diab Rep; 2003 Feb; 3(1):73-9. PubMed ID: 12643149
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome: therapeutic considerations.
Grundy SM
Handb Exp Pharmacol; 2005; (170):107-33. PubMed ID: 16596797
[TBL] [Abstract][Full Text] [Related]
4. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
[TBL] [Abstract][Full Text] [Related]
5. [The prevalence of metabolic syndrome in middle-aged in Kaunas population].
Gustiene O; Slapikas R; Klumbiene J; Sakalauskiene G; Kubilius R; Bagdzeviciūte S; Zaliūnas R
Medicina (Kaunas); 2005; 41(10):867-76. PubMed ID: 16272835
[TBL] [Abstract][Full Text] [Related]
6. Interrelationships between inflammation, C-reactive protein, and insulin resistance.
Ndumele CE; Pradhan AD; Ridker PM
J Cardiometab Syndr; 2006; 1(3):190-6. PubMed ID: 17679826
[TBL] [Abstract][Full Text] [Related]
7. What is the metabolic syndrome? Prediabetes and cardiovascular risk.
Borgman M; McErlean E
J Cardiovasc Nurs; 2006; 21(4):285-90. PubMed ID: 16823282
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome in obese Thai children and adolescents.
Iamopas O; Chongviriyaphan N; Suthutvoravut U
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S126-32. PubMed ID: 22043765
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome, a cardiovascular disease risk factor: role of adipocytokines and impact of diet and physical activity.
Robinson LE; Graham TE
Can J Appl Physiol; 2004 Dec; 29(6):808-29. PubMed ID: 15630152
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women.
Ridker PM; Buring JE; Cook NR; Rifai N
Circulation; 2003 Jan; 107(3):391-7. PubMed ID: 12551861
[TBL] [Abstract][Full Text] [Related]
11. Obesity and metabolic phenotypes (metabolically healthy and unhealthy variants) are significantly associated with prevalence of elevated C-reactive protein and hepatic steatosis in a large healthy Brazilian population.
Shaharyar S; Roberson LL; Jamal O; Younus A; Blaha MJ; Ali SS; Zide K; Agatston AA; Blumenthal RS; Conceição RD; Santos RD; Nasir K
J Obes; 2015; 2015():178526. PubMed ID: 25838943
[TBL] [Abstract][Full Text] [Related]
12. [Epidemiological data and screening criteria of the metabolic syndrome].
Boulogne A; Vantyghem MC
Presse Med; 2004 Jun; 33(10):662-5, 681. PubMed ID: 15257240
[TBL] [Abstract][Full Text] [Related]
13. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
[TBL] [Abstract][Full Text] [Related]
14. Risk factor clusters for metabolic syndrome in coronary heart disease: state of the science.
Saylor J
Dimens Crit Care Nurs; 2005; 24(2):64-9. PubMed ID: 15827427
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein.
Malik S; Wong ND; Franklin S; Pio J; Fairchild C; Chen R
Diabetes Care; 2005 Mar; 28(3):690-3. PubMed ID: 15735209
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk associated with the metabolic syndrome.
Lindsay RS; Howard BV
Curr Diab Rep; 2004 Feb; 4(1):63-8. PubMed ID: 14764282
[TBL] [Abstract][Full Text] [Related]
17. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
[TBL] [Abstract][Full Text] [Related]
18. The metabolic syndrome and cardiovascular disease: Part I.
Jiamsripong P; Mookadam M; Honda T; Khandheria BK; Mookadam F
Prev Cardiol; 2008; 11(3):155-61. PubMed ID: 18607151
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes in metabolic syndrome.
Bhatheja R; Bhatt DL
J Cardiovasc Nurs; 2006; 21(4):298-305. PubMed ID: 16823284
[TBL] [Abstract][Full Text] [Related]
20. Operative risk factors in the metabolic syndrome: is it lipids and high blood pressure or are there direct vascular effects of insulin resistance and obesity?
Ukkola O
Curr Cardiol Rep; 2006 Nov; 8(6):427-32. PubMed ID: 17059794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
